-
Mashup Score: 6Creating a Culture of Holistic Care in Lupus | GSK US - 11 day(s) ago
Lupus is a disease that flares and damages vital organs, GSK aims to improve lives through holistic care and a culture of health.
Source: us.gsk.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 11GSK invests up to $800 million in Pennsylvania site, largest manufacturing investment in U.S. | GSK US - 1 month(s) ago
GSK is outfitting its Marietta, Pennsylvania, site with new state-of-the-art facilities dedicated to producing medicines and vaccines.
Source: us.gsk.comCategories: General Medicine News, PayerTweet-
We’re proud to be investing in US manufacturing to bring products and innovation to patients faster. Thanks to @GovernorShapiro, @DCEDSecretary, @SenatorAument and PA Rep Tom Jones for helping to make our Marietta Pennsylvania site expansion possible! https://t.co/vjpnOWTlc6 https://t.co/ID2nQInPNX
-
-
Mashup Score: 11GSK invests up to $800 million in Pennsylvania site, largest manufacturing investment in U.S. | GSK US - 1 month(s) ago
GSK is outfitting its Marietta, Pennsylvania, site with new state-of-the-art facilities dedicated to producing medicines and vaccines.
Source: us.gsk.comCategories: General Medicine News, PayerTweet-
Breaking #News: We are making our largest US manufacturing investment to date: $800 million in our Pennsylvania site, able to manufacture both medicines and vaccines, double the size of the site and over 200 new jobs. Read more here: https://t.co/WsiKOrp6Mx https://t.co/0xIjRIzwkx
-
-
Mashup Score: 0
Single dose of vaccine elicited robust immune response with acceptable safety profile in adults aged 18-49 at increased risk for RSV-LRTD.
Source: us.gsk.comCategories: General Medicine News, PayerTweet-
#News for #Investors and #Media: Today we shared data on our RSV vaccine. Learn more: https://t.co/eWswjH425L https://t.co/ce8HwWtvDC
-
-
Mashup Score: 0GSK and ViiV Healthcare to showcase advances across industry-leading infectious disease portfolio at IDWeek 2024 | GSK US - 2 month(s) ago
60 abstracts to be presented across broad and growing portfolio of vaccines and medicines aimed at getting ahead of infectious disease.
Source: us.gsk.comCategories: General Medicine News, PayerTweet-
News for #Media and #Investors: Together with @ViiVHC, we’re presenting 60 abstracts to showcase advances across our industry-leading infectious disease pipeline and portfolio at #IDWeek2024. 🔗 Learn more: https://t.co/71aWD8UPQr
-
-
Mashup Score: 1GSK presents positive data for AREXVY, its respiratory syncytial virus (RSV) vaccine, indicating protection over three RSV seasons | GSK US - 2 month(s) ago
GSK will continue to provide data on longer-term follow-up to help recommending bodies determine future revaccination schedules
Source: us.gsk.comCategories: General Medicine News, PayerTweet-
#News for #Investors and #Media: Today we shared data at #CHEST2024 on one of our vaccines. Learn more: https://t.co/24dAcWuYME https://t.co/1kXhkjIcwS
-
-
Mashup Score: 0US charitable investments | GSK US - 2 month(s) ago
We invest with nonprofits that are doing good for people in need in the communities where we live and work
Source: us.gsk.comCategories: General Medicine News, PayerTweet-
In the spirit of supporting the communities where we live and work, GSK is providing funding to support #HurricaneHelene recovery and relief efforts in the southeast region of the US. #CommunitySupport #DisasterRelief 👉 Learn more: https://t.co/ejnjeCNrnM https://t.co/Kwh4Pc2R4b
-
-
Mashup Score: 1Multiple myeloma | GSK US - 2 month(s) ago
Multiple myeloma is the second most common blood cancer in the US, with an estimated 35,780 new cases to be diagnosed in 2021
Source: us.gsk.comCategories: General Medicine News, PayerTweet-
Each year, thousands in the U.S. are diagnosed with #MultipleMyeloma, the second most common blood cancer. It starts in bone marrow when plasma cells mutate. Learn more: https://t.co/8J80XZEUPL #BloodCancerAwarenessMonth https://t.co/z31MzdepgN
-
-
Mashup Score: 2Five for Five | GSK US - 2 month(s) ago
GSK encourages you to spend five minutes learning about the risks, symptoms, and importance of raising awareness for gynecologic cancers.
Source: us.gsk.comCategories: General Medicine News, PayerTweet-
Take five minutes to learn about some of the most common symptoms of #OvarianCancer. Since symptoms can mimic other common conditions, listen to your body and note any irregularities that may arise. Learn more: https://t.co/h2r4uYmODo. #OvarianCancerAwarenessMonth #5for5 https://t.co/64HT6Fk8Fi
-
-
Mashup Score: 1GSK announces positive topline data on co-administration of AREXVY and SHINGRIX | GSK US - 2 month(s) ago
GSK announced positive topline data from the phase 3 trial in adults 50 years and older evaluating the safety of AREXVY and SHINGRIX.
Source: us.gsk.comCategories: General Medicine News, PayerTweet-
#News for #investors and #media: today we announced data on two of our vaccines. Read more here: https://t.co/GOiD1POJEi https://t.co/0gibrZj0z6
-
Social factors can majorly impact a person’s health, especially for people from racial & ethnic minority groups living with #lupus. GSK is addressing these challenges & encouraging early intervention for those living with this condition: https://t.co/WfEM50i2Nv @ACRheum #ACR24 https://t.co/sirV5ETTZV